08:00 , Jan 7, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Early growth response 3 (EGR3) In vitro and mouse studies suggest that inhibiting EGR3 could help treat cancer. In primary human endothelial cells, knockdown...
02:52 , Feb 23, 2007 |  BC Extra  |  Clinical News

EGR genes downregulated in schizophrenia

Researchers from Riken Brain Science Institute and colleagues published in the Proceedings of the National Academy of Sciences that EGR3 , a gene in the calcineurin cascade, is a susceptibility candidate in the pathogenesis of...